Top 5 Home Health & Hospice Deals of 2023

Top 5 Home Health & Hospice Deals of 2023

The Home Health & Hospice (HH&H) market experienced a decline in deal activity, totaling 95 transactions, compared to the 113 announced in 2022. The deals were evenly distributed throughout the year, with 47 deals announced in the first half of 2023, and 48 deals announced in the second half. However, the larger transactions were announced at the start of the year, with approximately $4.7 billion in announced spending during the first half, and only $32 million announced during the second half, when there were much smaller deals and only one disclosed price. While large buyers dominated the start of the year, smaller buyers took the lead in the latter half.  Here are the top... Read More »
UnitedHealth Group Reports 14% Growth YoY, Expands Services & Customer Base

UnitedHealth Group Reports 14% Growth YoY, Expands Services & Customer Base

UnitedHealth Group Incorporated (NYSE: UNH), one of the largest health insurers in the United States, reported its third-quarter financial results on Friday, October 13. Last year, the company reported positive performance and balanced growth across its Optum and UnitedHealthcare business segments. This trend has continued into Q3:23, as the company’s growth in the third quarter was attributable to an increase in the number of people served by Optum and UnitedHealthcare, and the broadening scope of services offered. During Q3:23, UnitedHealth reported group revenues of $92.4 billion, up 14% from $80.9 billion in Q3:22. The company also announced Q3:23 earnings from operations of $8.5... Read More »
UnitedHealth Group Reports 14% Growth YoY, Expands Services & Customer Base

Q2:23 Thematic Earnings Roundup

This earnings season has provided us with insights into how various publicly traded healthcare companies are navigating the current landscape. Let’s delve into the trends and outcomes that defined the second quarter of 2023. The Home Health & Hospice Market: The Erosion of Medicare Fee-For-Service The Home Health & Hospice (HH&H) market has been volatile of late, with companies like Amedisys Inc. (NASDAQ: AMED) reporting a significant shortfall in earnings and a decline in revenue compared to the same period last year. Amedisys reported a financial loss in the second quarter of $80.3 million, after reporting a profit in the same 2022 period. A significant portion of this... Read More »
Dr. Amar Desai to Lead Optum Health as New CEO

Dr. Amar Desai to Lead Optum Health as New CEO

After less than six months in his role as president of health care delivery at CVS Health, Dr. Amar Desai is returning to UnitedHealth Group as the new CEO of Optum Health. The shift in leadership comes as Optum Health is growing its presence in the home health and hospice market. The company recently acquired two of the largest providers in the space – LHC Group and Amedisys Inc. – with price tags of $6 billion and more than $3.7 billion, respectively. In his role as Optum’s CEO, Dr. Desai will oversee operations of the company’s nearly 135,000 employees that provide home health, hospice and other services to 103 million patients nationwide. “I am looking forward to working with our... Read More »
LHC Group Buys Heart ‘n Home Hospice

LHC Group Buys Heart ‘n Home Hospice

The leading home health and hospice provider LHC Group, Inc. (NASDAQ: LHCG) is back with a new acquisition. The company is buying Heart ‘n Home Hospice, which has a total of six locations in southwestern Idaho and four locations in central and eastern Oregon. It also operates under the Treasure Valley Hospice brand.  LHC Group is a leading national provider of in-home healthcare services and the joint venture partner of choice for 350 hospitals in the U.S. The acquisition marks LHC’s initial entry into hospice services in the state of Oregon and expands its existing hospice footprint in Idaho. LHC Group expects annualized revenue from this purchase to reach approximately $20 million... Read More »